Cigna primarily provides pharmacy benefit management and health insurance services... Show more
The Cigna Group, a global health company with roughly 180 million customer relationships worldwide, operates through its Cigna Healthcare and Evernorth Health Services divisions. The company pays a quarterly cash dividend, currently set at $1.56 per share following the increase declared on February 5, 2026. At recent trading levels, this equates to an annual dividend of $6.24 per share and a dividend yield of approximately 2.42%. The most recent ex-dividend date was March 5, 2026, with the payment distributed on March 19, 2026. The next expected ex-dividend date falls on June 4, 2026.
Cigna does not position itself as a high-yield stock. Instead, it fits squarely into the dividend growth category — a company that prioritizes steady, meaningful annual increases backed by conservative financial management. With a payout ratio hovering around 27%, the dividend is supported by one of the lowest payout ratios in the managed care sector, making Cigna an under-the-radar name for investors who value dividend reliability and growth potential over maximum current income.
Cigna's modern dividend growth story began in earnest in 2021. Before that, the company paid a nominal quarterly dividend of just $0.04 per share for several years, functioning as little more than a placeholder. In 2021, management pivoted to a more shareholder-friendly capital allocation strategy, lifting the quarterly dividend to $1.00 per share. Since then, the progression has been consistent and robust:
Over a five-year span, the annualized dividend has grown from $4.00 to $6.24 — a cumulative increase of 56%. While the pace of annual increases has moderated as the base has grown larger, the direction remains firmly upward. Cigna has now delivered five consecutive years of dividend increases, and the February 2026 raise signals management's continued confidence in the company's earnings trajectory.
The standout feature of Cigna's dividend profile is its sustainability. The company's payout ratio of roughly 27% is among the lowest in the managed care industry. With earnings per share (EPS) of approximately $22.17, the annual dividend of $6.24 is covered more than 3.5 times by earnings alone — a margin of safety that is rare among dividend-paying healthcare stocks.
Free cash flow adds another layer of reassurance. Cigna generated approximately $9.77 billion in free cash flow, which covers the estimated $1.65 billion in annual dividend payments by a factor greater than five. This means the dividend is not competing with other capital allocation priorities — including debt management, strategic investments, and share buybacks — in any meaningful way. Even under a scenario of significant earnings compression, the current dividend would likely remain secure at earnings levels well below current results. The company's balance sheet and disciplined capital allocation philosophy further reinforce the durability of the payout.
Within the managed care and health insurance sector, Cigna's dividend yield of roughly 2.42% compares favorably. The average dividend yield for the healthcare sector sits around 1.55%, placing Cigna well above the industry norm. For context, peer companies such as UNH (UnitedHealth Group) and ELV (Elevance Health) typically carry yields closer to 1.3% to 1.5%. While CVS (CVS Health) offers a higher headline yield above 3%, that comes with a significantly higher payout ratio and a more uncertain earnings outlook.
What distinguishes Cigna from many peers is the combination of an above-average yield and an exceptionally low payout ratio. Most higher-yielding healthcare names achieve that yield by distributing a larger share of earnings, which can limit future dividend growth. Cigna's structure — a competitive yield with substantial retained earnings — positions it uniquely for continued payout expansion without stretching its financial resources.
For investors looking to identify dividend-paying stocks like The Cigna Group alongside other income-generating or growth-oriented opportunities, Tickeron's AI Screener offers a powerful, AI-driven stock and ETF discovery tool. The platform enables traders and investors to filter thousands of stocks and ETFs using customizable criteria such as industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and AI-generated trading signals. This screener is particularly valuable for dividend-focused investors, as it can help isolate stocks based on dividend yield, payout consistency, and fundamental strength. Whether searching for reliable income investments, breakout candidates, or trending sectors, the AI Screener simplifies the discovery process and surfaces opportunities faster than manual screening methods.
Cigna is best suited for dividend growth investors and total-return-oriented investors who prioritize payout durability, consistent annual increases, and strong free cash flow coverage over a high current yield. The roughly 2.42% yield, while above the sector average, is not deep enough to attract pure income investors who depend on distributions for near-term living expenses. However, the 27% payout ratio and the company's demonstrated commitment to raising the dividend each year since 2021 make CI a compelling candidate for those with longer time horizons.
The stock also appeals to investors who value total shareholder returns. Cigna's active share repurchase program — which carries a buyback yield above 5% — pushes the combined shareholder yield above 7.5%, a figure that rivals many high-yield alternatives without the associated payout risk. For conservative, long-term investors seeking a healthcare sector holding with a growing dividend, manageable risk, and a clear capital return strategy, Cigna merits close attention. That said, prospective investors should consider the broader regulatory environment for managed care companies and the potential impact of healthcare policy changes on the company's earnings profile.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a provider of health insurance services
Industry ManagedHealthCare